ctrl K

RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q4 2022	Q3 2022
Period Ending	Sep 30, 2023	Dec 31, 2022	Sep 30, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-60.06M	-38.41M	-20.95M
Interest Income	6.75M	3.26M	503K
Pretax Income	-53.34M	-35.15M	-20.45M
Net Income	-53.34M	-35.15M	-20.45M
Selling & General & Admin	8.3M	4.82M	2.12M
Research & Development	51.76M	33.59M	18.83M
Other Expenses	-30K	n/a	n/a
Operating Expenses	60.06M	38.41M	20.95M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	60.06M	38.41M	20.95M
Income Tax Expense	-3.49M	n/a	n/a
Shares Outstanding (Basic)	15.4M	n/a	40.31M
Shares Outstanding (Diluted)	15.4M	n/a	40.31M
EPS (Basic)	-1.69	-0.51	-0.51
EPS (Diluted)	-1.69	-0.51	-0.51
EBITDA	-58.74M	-37.59M	-20.55M
EBIT	n/a	n/a	n/a
Depreciation & Amortization	1.32M	823K	404K